Patent · US Active

Vaccines for malaria

US9364525B2 · kind B2 · utility

1Cited by
13References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2007
Grant dateJun 14, 2016
Priority date
Expiry dateApr 28, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. In particular it relates to an immunogenic protein particle comprising the following monomers:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.